These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 37985008)
1. Correlation between antibodies against the pathogenic pHERV-W envelope protein and the inflammatory phase of multiple sclerosis. Ruberto S; Cossu D; Sechi LA Immunology; 2024 Feb; 171(2):270-276. PubMed ID: 37985008 [TBL] [Abstract][Full Text] [Related]
3. pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Kremer D; Gruchot J; Weyers V; Oldemeier L; Göttle P; Healy L; Ho Jang J; Kang T Xu Y; Volsko C; Dutta R; Trapp BD; Perron H; Hartung HP; Küry P Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15216-15225. PubMed ID: 31213545 [TBL] [Abstract][Full Text] [Related]
4. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. Mameli G; Poddighe L; Mei A; Uleri E; Sotgiu S; Serra C; Manetti R; Dolei A PLoS One; 2012; 7(9):e44991. PubMed ID: 23028727 [TBL] [Abstract][Full Text] [Related]
5. Lack of immune responses against multiple sclerosis-associated retrovirus/human endogenous retrovirus W in patients with multiple sclerosis. Ruprecht K; Gronen F; Sauter M; Best B; Rieckmann P; Mueller-Lantzsch N J Neurovirol; 2008 Apr; 14(2):143-51. PubMed ID: 18444086 [TBL] [Abstract][Full Text] [Related]
6. Human Endogenous Retrovirus Type W Envelope from Multiple Sclerosis Demyelinating Lesions Shows Unique Solubility and Antigenic Characteristics. Charvet B; Pierquin J; Brunel J; Gorter R; Quétard C; Horvat B; Amor S; Portoukalian J; Perron H Virol Sin; 2021 Oct; 36(5):1006-1026. PubMed ID: 33770381 [TBL] [Abstract][Full Text] [Related]
7. Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences. Laufer G; Mayer J; Mueller BF; Mueller-Lantzsch N; Ruprecht K Retrovirology; 2009 Apr; 6():37. PubMed ID: 19368703 [TBL] [Abstract][Full Text] [Related]
8. Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. Curtin F; Perron H; Kromminga A; Porchet H; Lang AB MAbs; 2015; 7(1):265-75. PubMed ID: 25427053 [TBL] [Abstract][Full Text] [Related]
9. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Antony JM; Deslauriers AM; Bhat RK; Ellestad KK; Power C Biochim Biophys Acta; 2011 Feb; 1812(2):162-76. PubMed ID: 20696240 [TBL] [Abstract][Full Text] [Related]
10. Potential molecular mimicry between the human endogenous retrovirus W family envelope proteins and myelin proteins in multiple sclerosis. Ramasamy R; Joseph B; Whittall T Immunol Lett; 2017 Mar; 183():79-85. PubMed ID: 28189601 [TBL] [Abstract][Full Text] [Related]
11. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis. van Horssen J; van der Pol S; Nijland P; Amor S; Perron H Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869 [TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of human endogenous retrovirus-W env in neuroinflammatory diseases. Antony JM; Izad M; Bar-Or A; Warren KG; Vodjgani M; Mallet F; Power C AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1253-9. PubMed ID: 17209768 [TBL] [Abstract][Full Text] [Related]
13. Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. Mameli G; Poddighe L; Astone V; Delogu G; Arru G; Sotgiu S; Serra C; Dolei A J Virol Methods; 2009 Oct; 161(1):98-106. PubMed ID: 19505508 [TBL] [Abstract][Full Text] [Related]
14. Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. Arru G; Leoni S; Pugliatti M; Mei A; Serra C; Delogu LG; Manetti R; Dolei A; Sotgiu S; Mameli G Mult Scler; 2014 Feb; 20(2):174-82. PubMed ID: 23877972 [TBL] [Abstract][Full Text] [Related]
15. Syncytin-1/HERV-W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients. Garcia-Montojo M; Rodriguez-Martin E; Ramos-Mozo P; Ortega-Madueño I; Dominguez-Mozo MI; Arias-Leal A; García-Martínez MÁ; Casanova I; Galan V; Arroyo R; Álvarez-Lafuente R; Villar LM Eur J Immunol; 2020 May; 50(5):685-694. PubMed ID: 32012247 [TBL] [Abstract][Full Text] [Related]
16. Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. Mameli G; Astone V; Arru G; Marconi S; Lovato L; Serra C; Sotgiu S; Bonetti B; Dolei A J Gen Virol; 2007 Jan; 88(Pt 1):264-274. PubMed ID: 17170460 [TBL] [Abstract][Full Text] [Related]
17. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. Balestrieri E; Minutolo A; Petrone V; Fanelli M; Iannetta M; Malagnino V; Zordan M; Vitale P; Charvet B; Horvat B; Bernardini S; Garaci E; di Francesco P; Sinibaldi Vallebona P; Sarmati L; Grelli S; Andreoni M; Perron H; Matteucci C EBioMedicine; 2021 Apr; 66():103341. PubMed ID: 33867312 [TBL] [Abstract][Full Text] [Related]
18. Humoral immunity response to human endogenous retroviruses K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases. Arru G; Mameli G; Deiana GA; Rassu AL; Piredda R; Sechi E; Caggiu E; Bo M; Nako E; Urso D; Mariotto S; Ferrari S; Zanusso G; Monaco S; Sechi G; Sechi LA Eur J Neurol; 2018 Aug; 25(8):1076-e84. PubMed ID: 29603839 [TBL] [Abstract][Full Text] [Related]